Surgery Partners, Inc. (NASDAQ:SGRY – Get Free Report) has earned an average rating of “Moderate Buy” from the eleven analysts that are presently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have assigned a buy rating to the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $19.00.
Several equities analysts have recently weighed in on SGRY shares. Zacks Research cut Surgery Partners from a “strong-buy” rating to a “hold” rating in a report on Monday, August 10th. JPMorgan Chase & Co. boosted their price target on Surgery Partners from $14.00 to $15.00 and gave the stock a “neutral” rating in a research report on Monday, September 14th. Weiss Ratings raised Surgery Partners from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, October 16th. Cantor Fitzgerald reiterated an “overweight” rating on shares of Surgery Partners in a research note on Friday, October 2nd. Finally, Royal Bank Of Canada reissued an “outperform” rating and issued a $19.00 price objective on shares of Surgery Partners in a report on Wednesday, September 30th.
Check Out Our Latest Research Report on SGRY
Insiders Place Their Bets
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently modified their holdings of SGRY. Jupiter Topco LLC acquired a new stake in shares of Surgery Partners in the second quarter valued at approximately $233,220,000. Pentwater Capital Management LP acquired a new position in shares of Surgery Partners during the 2nd quarter worth approximately $195,384,000. BlackRock Inc. acquired a new position in shares of Surgery Partners during the 2nd quarter worth approximately $104,857,000. Hsbc Holdings PLC acquired a new position in shares of Surgery Partners during the 2nd quarter worth approximately $48,912,000. Finally, Bank of America Corp DE acquired a new position in shares of Surgery Partners during the 2nd quarter worth approximately $20,374,000.
Surgery Partners Stock Performance
Shares of SGRY stock opened at $15.75 on Tuesday. The company’s fifty day simple moving average is $14.21 and its 200-day simple moving average is $14.56. The company has a quick ratio of 1.78, a current ratio of 1.95 and a debt-to-equity ratio of 1.18. The firm has a market cap of $2.06 billion, a PE ratio of -22.50, a P/E/G ratio of 4.87 and a beta of 1.90. Surgery Partners has a 12 month low of $11.41 and a 12 month high of $23.44.
Surgery Partners (NASDAQ:SGRY – Get Free Report) last announced its earnings results on Monday, August 10th. The company reported $0.10 EPS for the quarter, topping the consensus estimate of $0.06 by $0.04. Surgery Partners had a negative net margin of 2.63% and a positive return on equity of 0.88%. The business had revenue of $848.90 million during the quarter, compared to analysts’ expectations of $830.03 million. During the same quarter in the prior year, the company posted $0.17 earnings per share. The firm’s revenue was up 2.7% on a year-over-year basis. Equities research analysts expect that Surgery Partners will post 0.25 EPS for the current fiscal year.
Surgery Partners Company Profile
Surgery Partners, Inc is a U.S.-based healthcare services company that operates and manages ambulatory surgery centers and surgical hospitals. The company works with physicians, health systems and other healthcare providers to deliver outpatient surgical care in facilities designed for same-day procedures.
Its facilities provide surgical services across specialties such as orthopedics, pain management, ophthalmology, gastroenterology, urology, gynecology and general surgery. Surgery Partners also supports its operations with clinical, administrative and revenue-cycle services intended to help physicians and facility partners manage patient care and practice operations.
Founded in 2004 and headquartered in Brentwood, Tennessee, Surgery Partners has expanded its platform through acquisitions, joint ventures and other partnerships.
Further Reading
- Five stocks we like better than Surgery Partners
- Bloom Energy Just Reported—Its Biggest Order Is Still Waiting on a Pipeline
- Why Western Digital’s AI Storage Boom Defies the Chip Sell-Off
- Grand Canyon Education Strengthens Its Outlook, But Wall Street Remains Divided
- Amex Stock Slides on Job Cuts, But the Real Story Is Macro
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.
